That's what happened in the case of new weight-loss drugs, known as GLP-1 agonists, that have exploded in popularity in the past couple of years
Although the ELIXA studythe only CVD outcome trial of GLP-1 RAs published to datereported a neutral cardiovascular effect of lixisenatide, the potential cardiovascular benefits of GLP-1 RAs should not be overlooked, because high-risk subjects with established CVD were recruited in this study to delineate its cardiovascular safety within a short-term period
In this regard, GLP-1RAs have shown promising efficacy as to the improvement of hard cardiovascular outcomes with cardiovascular safety
Exhaling slowly during needle insertion relaxes the tissue
Creatine works by replenishing phosphocreatine stores in muscle cells, which supports energy production during physical activity and helps maintain muscle volume even when calories are restricted
This early window reflects the drug's activation of GLP-1 receptors in your hypothalamus, the brain region controlling hunger signals and fullness cues
